Article Information
History
- May 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Phillip R. Pittman1,*,¶,
- James W. Martin1,2,¶,
- Placide Mbala Kingebeni3,4,
- Jean-Jacques Muyembe Tamfum3,
- Qingwen Wan1,
- Mary G. Reynolds5,
- Xiaofei Quinn1,
- Sarah Norris1,
- Michael B. Townsend5,
- Panayampalli S. Satheshkumar5,
- Bryony Soltis,
- Anna Honko,
- Fernando B. Güereña1,
- Lawrence Korman1,
- John W. Huggins1 and
- The Kole Human Monkeypox Infection Study Group^
- 1Division of Medicine, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD, USA
- 2Walter Reed National Military Medical Center, Bethesda, MD
- 3Institut National de Recherche Biomédicale, Ministère de la Santé Publique, Kinshasa-Gombe B.P. 1197, Democratic Republic of the Congo (DRC)
- 4L’Hôpital Général de Référence de Kole, Kole, Democratic Republic of the Congo
- 5Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, NE, Atlanta, GA
- ↵*Corresponding author E-mail: phillip.r.pittman.civ{at}mail.mil
↵¶ Co-first authors contributed equally to this work.
Posted May 29, 2022.
Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo
